Short-term interval aerobic exercise training does not improve memory functioning in relapsing-remitting multiple sclerosis-a randomized controlled trial

被引:28
作者
Baguet, Lisa [1 ]
Hasselmann, Helge [2 ]
Patra, Stefan [3 ,4 ]
Stellmann, Jan-Patrick [1 ,5 ]
Vettorazzi, Eik [6 ]
Engel, Andreas K. [7 ]
Rosenkranz, Sina Catherine [1 ]
Poettgen, Jana [1 ,5 ]
Gold, Stefan Michael [1 ,2 ]
Schulz, Karl-Heinz [3 ,4 ]
Heesen, Christoph [1 ,5 ]
机构
[1] Univ Med Ctr Hamburg Eppendorf, Inst Neuroimmunol & Multiple Sclerosis INIMS, Hamburg, Germany
[2] Charite Univ Med Berlin, Dept Psychiat & Psychotherapy, Campus Benjamin Franklin, Berlin, Germany
[3] Univ Med Ctr Hamburg Eppendorf, Univ Kompetenzzentrum Sport & Bewegungsmed Athlet, Hamburg, Germany
[4] Univ Med Ctr Hamburg Eppendorf, Inst & Poliklin Med Psychol, Hamburg, Germany
[5] Univ Med Ctr Hamburg Eppendorf, Dept Neurol, Hamburg, Germany
[6] Univ Med Ctr Hamburg Eppendorf, Inst Med Biometry & Epidemiol, Hamburg, Germany
[7] Univ Med Ctr Hamburg Eppendorf, Dept Neurophysiol & Pathophysiol, Hamburg, Germany
来源
PEERJ | 2018年 / 6卷
关键词
Multiple sclerosis; Cognition; Memory function; Aerobic exercise training; Neuroimmunology; Neurorehabilitation; QUALITY-OF-LIFE; DEPRESSIVE SYMPTOMATOLOGY; COGNITIVE IMPAIRMENT; PROCESSING SPEED; FITNESS; IMPACT; SCALE; NEUROPLASTICITY; VALIDATION; FATIGUE;
D O I
10.7717/peerj.6037
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background: Only few aerobic exercise intervention trials specifically targeting cognitive functioning have been performed in multiple sclerosis. Objective and Methods: This randomized controlled trial with 34 patients in the intervention group (IG) (mean: 38.2 years (+/- 9.6)) and 34 patients in the control group (CG) (mean: 39.6 years (+/- 9.7)) aimed to determine the effects of aerobic exercise on cognition in relapsing-remitting multiple sclerosis (RRMS). The primary outcome was verbal learning assessed by the verbal learning and memory test (VLMT). Patients were randomized to an IG or a waitlist CG. Patients in the IG exercised according to an individually tailored training schedule (with two to three sessions per week for 12 weeks). The primary analysis was carried out using the intention-to-treat (ITT) sample with ANCOVA adjusting for baseline scores. Results: A total of 77 patients with RRMS were screened and 68 participants randomized (CG n = 34; IG n = 34). The sample comprised 68% females, had a mean age of 39 years, a mean disease duration of 6.3 years, and a mean expanded disability status scale of 1.8. No significant effects were detected in the ITT analysis for the primary endpoint VLMT or any other cognitive measures. Moreover, no significant treatment effects were observed for quality of life, fatigue, or depressive symptoms. Conclusion: This study failed to demonstrate beneficial effects of aerobic exercise on cognition in RRMS.
引用
收藏
页数:18
相关论文
共 50 条
  • [31] A randomized placebo-controlled trial of delayed-release dimethyl fumarate in patients with relapsing-remitting multiple sclerosis from East Asia and other countries
    Takahiko Saida
    Takashi Yamamura
    Takayuki Kondo
    Jang Yun
    Minhua Yang
    Jie Li
    Lalitha Mahadavan
    Bing Zhu
    Sarah I. Sheikh
    [J]. BMC Neurology, 19
  • [32] Effect of peginterferon beta-1a on MRI measures and achieving no evidence of disease activity: results from a randomized controlled trial in relapsing-remitting multiple sclerosis
    Douglas L Arnold
    Peter A Calabresi
    Bernd C Kieseier
    Sarah I Sheikh
    Aaron Deykin
    Ying Zhu
    Shifang Liu
    Xiaojun You
    Bjoern Sperling
    Serena Hung
    [J]. BMC Neurology, 14
  • [33] Effect of peginterferon beta-1a on MRI measures and achieving no evidence of disease activity: results from a randomized controlled trial in relapsing-remitting multiple sclerosis
    Arnold, Douglas L.
    Calabresi, Peter A.
    Kieseier, Bernd C.
    Sheikh, Sarah I.
    Deykin, Aaron
    Zhu, Ying
    Liu, Shifang
    You, Xiaojun
    Sperling, Bjoern
    Hung, Serena
    [J]. BMC NEUROLOGY, 2014, 14
  • [34] A randomized placebo-controlled trial of delayed-release dimethyl fumarate in patients with relapsing-remitting multiple sclerosis from East Asia and other countries
    Saida, Takahiko
    Yamamura, Takashi
    Kondo, Takayuki
    Yun, Jang
    Yang, Minhua
    Li, Jie
    Mahadavan, Lalitha
    Zhu, Bing
    Sheikh, Sarah I.
    [J]. BMC NEUROLOGY, 2019, 19 (1)
  • [35] Probiotic supplementation and systemic inflammation in relapsing-remitting multiple sclerosis: A randomized, double-blind, placebo-controlled trial (vol 16, 901846, 2022)
    Rahimlou, Mehran
    Nematollahi, Shima
    Husain, Durdana
    Banaei-Jahromi, Nasrin
    Majdinasab, Nastaran
    Hosseini, Seyed Ahmad
    [J]. FRONTIERS IN NEUROSCIENCE, 2022, 16
  • [36] Short-term MRI measurements as predictors of EDSS progression in relapsing-remitting multiple sclerosis: grey matter atrophy but not lesions are predictive in a real-life setting
    von Gumberz, Johanna
    Mahmoudi, Mina
    Young, Kim
    Schippling, Sven
    Martin, Roland
    Heesen, Christoph
    Siemonsen, Susanne
    Stellmann, Jan-Patrick
    [J]. PEERJ, 2016, 4
  • [37] Assessing the Long-Term Effectiveness of Cladribine vs. Placebo in the Relapsing-Remitting Multiple Sclerosis CLARITY Randomized Controlled Trial and CLARITY Extension Using Treatment Switching Adjustment Methods
    Helen Bell Gorrod
    Nicholas R. Latimer
    Doris Damian
    Robert Hettle
    Gerard T. Harty
    Schiffon L. Wong
    [J]. Advances in Therapy, 2020, 37 : 225 - 239
  • [38] Assessing the Long-Term Effectiveness of Cladribine vs. Placebo in the Relapsing-Remitting Multiple Sclerosis CLARITY Randomized Controlled Trial and CLARITY Extension Using Treatment Switching Adjustment Methods
    Gorrod, Helen Bell
    Latimer, Nicholas R.
    Damian, Doris
    Hettle, Robert
    Harty, Gerard T.
    Wong, Schiffon L.
    [J]. ADVANCES IN THERAPY, 2020, 37 (01) : 225 - 239
  • [39] Does psychodynamic short-term psychotherapy for depressed breast cancer patients also improve fatigue? Results from a randomized controlled trial
    Weissflog, Gregor
    Braehler, Elmar
    Leuteritz, Katja
    Barthel, Yvette
    Kuhnt, Susanne
    Wiltink, Joerg
    Zwerenz, Ruediger
    Beutel, Manfred E.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2015, 152 (03) : 581 - 588
  • [40] Effect of eight weeks respiratory muscle training on respiratory capacity, functional capacity and quality of life on subjects with mild to moderate relapsing-remitting multiple sclerosis: A single-blinded randomized controlled trial
    Ghannadi, Shima
    Noormohammadpour, Pardis
    Mazaheri, Reza
    Sahraian, Mohammad Ali
    Mansournia, Mohammad Ali
    Shahi, Mohammad Hosein Pourgharib
    Fard, Amir Hesam Salmasi
    Abolhasani, Maryam
    [J]. MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2022, 68